Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
J Vis Exp ; (182)2022 04 12.
Article in English | MEDLINE | ID: mdl-35499356

ABSTRACT

The capillary aerosol generator (CAG) is operated with the principal of thermal liquid evaporation through heating of e-liquid in the initial phase, followed by nucleation and condensation regulated through a mixture of airflow to generate aerosols, such as in an electronic cigarette (EC). The CAG is particularly useful in generating aerosols of large volumes in a continuous manner, for instances such as in vivo inhalation toxicology studies, where usage of ECs is not feasible. The thermal effects of generating aerosol from the CAG are similar in terms of temperature applied in an EC, thus allowing investigators to assess the vapors of e-liquids at scale and reproducibility. As the operation of the CAG allows users to control critical parameters such as the flow rate of e-liquid, heating temperatures and dilution air flows, it allows investigators to test various e-liquid formulations in a well-controlled device. Properties, such as aerosol particle size, are demonstrated to be regulated with the air flow rate with respect to the e-liquid flow and e-liquid composition. The CAG, however, is limited in assessing common EC-related issues, such as overheating of its elements. We seek to demonstrate that the CAG can generate aerosol that is reproducible and continuous, by assessing the chemical and physical aerosol characteristics with a chosen e-liquid formulation. The protocol describes the operating parameters of liquid flow rate, dilution air-flow rates and operating procedures needing to optimize the aerosol concentration and particle size required for an in vivo toxicology study. Presenting the representative results from the protocol and discussing the challenges and applications of working with a CAG, we demonstrate that CAG can be used in a reproducible fashion. The technology and protocol, that has been developed from prior work, serve as a foundation for future innovations for laboratory-controlled aerosol generation investigations.


Subject(s)
Electronic Nicotine Delivery Systems , Aerosols , Particle Size , Reproducibility of Results , Veins
2.
Bioorg Med Chem Lett ; 18(9): 2935-8, 2008 May 01.
Article in English | MEDLINE | ID: mdl-18400497

ABSTRACT

A new series of amino-acetonitrile derivatives (AAD) have been discovered that exhibit high anthelmintic activity against parasitic nematode species such as Haemonchus contortus and Trichostrongylus colubriformis. Significantly, these compounds also demonstrate activity against nematode strains resistant to the currently available broad-spectrum anthelmintics. The discovery, synthesis, structure-activity relationship and biological results are presented.


Subject(s)
Aminoacetonitrile/pharmacology , Anthelmintics/pharmacology , Haemonchus/drug effects , Trichostrongylus/drug effects , Aminoacetonitrile/analogs & derivatives , Aminoacetonitrile/chemical synthesis , Animals , Anthelmintics/chemical synthesis , Dose-Response Relationship, Drug , Models, Chemical , Parasitic Sensitivity Tests , Structure-Activity Relationship
3.
Nature ; 452(7184): 176-80, 2008 Mar 13.
Article in English | MEDLINE | ID: mdl-18337814

ABSTRACT

Anthelmintic resistance in human and animal pathogenic helminths has been spreading in prevalence and severity to a point where multidrug resistance against the three major classes of anthelmintics--the benzimidazoles, imidazothiazoles and macrocyclic lactones--has become a global phenomenon in gastrointestinal nematodes of farm animals. Hence, there is an urgent need for an anthelmintic with a new mode of action. Here we report the discovery of the amino-acetonitrile derivatives (AADs) as a new chemical class of synthetic anthelmintics and describe the development of drug candidates that are efficacious against various species of livestock-pathogenic nematodes. These drug candidates seem to have a novel mode of action involving a unique, nematode-specific clade of acetylcholine receptor subunits. The AADs are well tolerated and of low toxicity to mammals, and overcome existing resistances to the currently available anthelmintics.


Subject(s)
Aminoacetonitrile/analogs & derivatives , Aminoacetonitrile/pharmacology , Anthelmintics/classification , Anthelmintics/pharmacology , Drug Resistance , Nematoda/drug effects , Parasitic Diseases, Animal/parasitology , Aging , Amino Acid Sequence , Aminoacetonitrile/adverse effects , Aminoacetonitrile/pharmacokinetics , Animals , Anthelmintics/chemistry , Anthelmintics/pharmacokinetics , Caenorhabditis elegans/drug effects , Caenorhabditis elegans/genetics , Caenorhabditis elegans/metabolism , Caenorhabditis elegans Proteins/chemistry , Caenorhabditis elegans Proteins/genetics , Caenorhabditis elegans Proteins/metabolism , Cattle , Cattle Diseases/drug therapy , Cattle Diseases/parasitology , Drug Resistance/genetics , Larva/drug effects , Larva/genetics , Molecular Sequence Data , Nematoda/genetics , Nematoda/physiology , Parasitic Diseases, Animal/drug therapy , Receptors, Nicotinic/chemistry , Receptors, Nicotinic/genetics , Receptors, Nicotinic/metabolism , Sheep/parasitology , Sheep Diseases/drug therapy , Sheep Diseases/parasitology
SELECTION OF CITATIONS
SEARCH DETAIL
...